Back to Search
BARBARA CONLEY, M.D
M.D
Medical Oncology Physician
NPI: 1508894445Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
4301042358(MI)
Research & Publications (20)
Targeting epigenetic abnormalities with histone deacetylase inhibitors.
PMID 16826577·Cancer·2006
6-review
Facile oxy-functionalization of a nucleophilic metal alkyl with a cis-dioxo metal species via a (2+3) transition state.
PMID 18773396·Angew Chem Int Ed Engl·2008
8-other
Facile functionalization of a metal carbon bond by O-atom transfer.
PMID 16834359·J Am Chem Soc·2006
8-other
Oxy-functionalization of nucleophilic rhenium(I) metal carbon bonds catalyzed by selenium(IV).
PMID 19161305·J Am Chem Soc·2009
8-other
Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects.
PMID 19370805·Curr Opin Oncol·2009
6-review
Histone deacetylation : an attractive target for cancer therapy?
PMID 18989989·Drugs R D·2008
6-review
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.
PMID 18641660·Nat Med·2008
4-observational
Salivary gland cancers: current treatments, molecular characteristics and new therapies.
PMID 18402531·Expert Rev Anticancer Ther·2008
6-review
A murine respiratory-inducing niche displays variable efficiency across human and mouse embryonic stem cell species.
PMID 17220377·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
PMID 17470851·J Clin Oncol·2007
2-rct
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.
PMID 17875771·Clin Cancer Res·2007
3-trial
Endoglin is required for myogenic differentiation potential of neural crest stem cells.
PMID 17628518·Dev Biol·2007
7-preclinical
BMPs regulate differentiation of a putative visceral endoderm layer within human embryonic stem-cell-derived embryoid bodies.
PMID 17464352·Biochem Cell Biol·2007
8-other
Novel biochemical pathways of endoglin in vascular cell physiology.
PMID 17975795·J Cell Biochem·2007
6-review
Treatment of advanced head and neck cancer: what lessons have we learned?
PMID 16505419·J Clin Oncol·2006
8-other
Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors.
PMID 16785228·J Biol Chem·2006
8-other
Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor.
PMID 16028097·Cancer Chemother Pharmacol·2006
4-observational
A general theory of evolution based on energy efficiency: its implications for diseases.
PMID 16122878·Med Hypotheses·2006
7-preclinical
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma.
PMID 16005577·Int J Radiat Oncol Biol Phys·2005
8-other
Clinical trial designs for predictive marker validation in cancer treatment trials.
PMID 15774793·J Clin Oncol·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 W GREENLAWN AVE
LANSING, MI 48910 - Phone
- (517) 975-9500
Quick Facts
- NPI
- 1508894445
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile